WALTHAM, Mass.--(BUSINESS WIRE)--Nomir Medical Technologies, a leader in the development of optical energy technologies for anti-infective medical applications, announced today that the Company will present an abstract detailing positive in vivo human data from its study of Methicillin-resistant S. aureus (MRSA) resistance reversal and eradication in the nares (nose) using Noveon®, a novel dual-wavelength optical energy device. Noveon is designed to effect near-infrared photo-damage and photo-inactivation of bacteria and fungi at energies and temperatures that are safe to normal and healthy tissue.
